Cargando…
Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
Triple negative breast cancer (TNBC) is associated with unfavorable prognosis and high relapse rates following chemotherapy. There is an urgent need to develop effective targeted therapy for this BC subtype. The type I insulin-like growth factor receptor (IGF-IR) was identified as a potential target...
Autores principales: | Tsui, Jennifer, Qi, Shu, Perrino, Stephanie, Leibovitch, Matthew, Brodt, Pnina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065809/ https://www.ncbi.nlm.nih.gov/pubmed/33916323 http://dx.doi.org/10.3390/biom11040527 |
Ejemplares similares
-
Inhibition of IGF signalling pathway in MDA-MB-231 triple negative breast cancer cells
por: Chandran, S, et al.
Publicado: (2012) -
Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020) -
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
por: D’Aloia, Alessia, et al.
Publicado: (2022) -
hnRNPK S379 phosphorylation participates in migration regulation of triple negative MDA-MB-231 cells
por: Tsai, Hsin-Yu, et al.
Publicado: (2019) -
PRIMA-1(MET) Does Not Restore Vitamin
D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast
Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)